Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-04 1:29 pm Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | AdvisorShares Trust | 20,543 4.710% | -131,901 (-86.52%) | View |
| 2024-11-14 7:32 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Lind Global Fund II LP | 44,500 9.900% | 44,500 (New Position) | View |
| 2024-11-05 1:46 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | AdvisorShares Trust | 152,444 34.960% | 152,444 (New Position) | View |
| 2024-02-06 5:26 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Lind Global Fund II LP | 1,410,800 9.900% | 1,410,800 (New Position) | View |
| 2023-02-09 11:32 am Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | VANGUARD GROUP INC | 5,016,741 4.680% | -129,742 (-2.52%) | View |
| 2022-07-08 4:57 pm Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | BlackRock Inc. BLK | 1,779,835 1.700% | -4,783,219 (-72.88%) | View |
| 2022-02-10 08:37 am Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | VANGUARD GROUP INC | 5,146,483 5.030% | 2,346,629 (+83.81%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | BlackRock Inc. BLK | 6,563,054 6.400% | 6,563,054 (New Position) | View |
| 2021-02-10 11:52 am Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | VANGUARD GROUP INC | 2,799,854 5.240% | 2,799,854 (New Position) | View |
| 2021-01-15 4:11 pm Unchanged | 13G | SEELOS THERAPEUTICS INC PA SEELQ | LIGAND PHARMACEUTICALS INC LGND | 2,224,000 4.100% | 0 (Unchanged) | View |
| 2021-01-11 4:02 pm Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Phoenixus AG | 0 0.000% | -2,000,227 (Position Closed) | View |
| 2020-02-14 1:32 pm Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | ARMISTICE CAPITAL LLC | 0 0.000% | -318,730 (Position Closed) | View |
| 2020-02-14 10:14 am Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Altium Capital Management LP | 0 0.000% | -228,676 (Position Closed) | View |
| 2020-02-12 4:05 pm Unchanged | 13G | SEELOS THERAPEUTICS INC PA SEELQ | LIGAND PHARMACEUTICALS INC LGND | 2,224,000 8.100% | 0 (Unchanged) | View |
| 2020-02-10 3:17 pm Sale | 13G | SEELOS THERAPEUTICS INC PA SEELQ | CVI Investments Inc. | 491,126 1.800% | -199,437 (-28.88%) | View |
| 2020-01-16 6:28 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEELQ | Phoenixus AG | 2,000,227 6.900% | 2,000,227 (New Position) | View |